Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats
about
Adhesion molecules in CNS disorders: biomarker and therapeutic targetsArachnoid cell involvement in the mechanism of coagulation-initiated inflammation in the subarachnoid space after subarachnoid hemorrhage.CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage.A novel CCM1 mutation associated with multiple cerebral and vertebral cavernous malformationsLeukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage.A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].A review of medical treatments of cerebral vasospasm.Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a reviewSystemic administration of LPS worsens delayed deterioration associated with vasospasm after subarachnoid hemorrhage through a myeloid cell-dependent mechanismInflammation, vasospasm, and brain injury after subarachnoid hemorrhage.Effectiveness of papaverine cisternal irrigation for cerebral vasospasm after aneurysmal subarachnoid hemorrhage and measurement of biomarkers.A Propensity Score-Matched Study of the Use of Non-steroidal Anti-inflammatory Agents Following Aneurysmal Subarachnoid Hemorrhage.Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage.
P2860
Q27015967-0B104DF0-EA87-41EA-BF80-25B11E3960B0Q33622668-3449C208-8722-47E8-BE1B-44742394901EQ33749272-558BFB28-F1F9-4ADA-AF03-2EBC2C106B38Q34538551-32DC4D63-2DDF-4B85-AC43-6BC78558F76FQ34590205-1756B2FE-94DA-4838-B611-3BB2ADF3D793Q35703367-0DC18442-0C85-4D1B-A0CC-45A020BC9D56Q37309288-4E618BCA-3B9B-46B7-8080-29A767470DE1Q38034460-324DB748-5B46-4C8A-85B1-CA560B9B07CDQ41933919-4ED1871D-89B5-499F-B0ED-88834171AEA9Q41958830-111E9BC1-1806-41F4-BF46-22E5A4FD152EQ44748057-6532F145-C442-4667-AEC5-10BB6D5EFC64Q48820445-055C5315-94C8-4D96-AF0E-16DFCEEBC597Q54349093-149C1B75-5B21-4EEB-980F-EA27FF9F8F68
P2860
Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats
description
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im September 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/09/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/09/01)
@nl
наукова стаття, опублікована у вересні 2002
@uk
مقالة علمية (نشرت في سبتمبر 2002)
@ar
name
Inhibition of vasospasm with l ...... a femoral artery model in rats
@ast
Inhibition of vasospasm with l ...... a femoral artery model in rats
@en
Inhibition of vasospasm with l ...... a femoral artery model in rats
@nl
type
label
Inhibition of vasospasm with l ...... a femoral artery model in rats
@ast
Inhibition of vasospasm with l ...... a femoral artery model in rats
@en
Inhibition of vasospasm with l ...... a femoral artery model in rats
@nl
prefLabel
Inhibition of vasospasm with l ...... a femoral artery model in rats
@ast
Inhibition of vasospasm with l ...... a femoral artery model in rats
@en
Inhibition of vasospasm with l ...... a femoral artery model in rats
@nl
P2093
P1476
Inhibition of vasospasm with l ...... a femoral artery model in rats
@en
P2093
Drew M. Pardoll
Eric M. Oshiro
Gregory N. Dietsch
Patricia A. Hoffman
Rafael J. Tamargo
Richard E. Clatterbuck
P304
P356
10.3171/JNS.2002.97.3.0676
P577
2002-09-01T00:00:00Z